Kim Hanbi, Huh Hee Jae, Park Eunkyoung, Chung Doo-Ryeon, Kang Minhee
Biomedical Engineering Research Center, Smart Healthcare Research Institute, Samsung Medical Center, Seoul, 06351 South Korea.
Department of Medical Device Management and Research, SAIHST (Samsung Advanced Institute for Health Sciences & Technology), Sungkyunkwan University, Seoul, 06355 South Korea.
Biochip J. 2021;15(1):14-22. doi: 10.1007/s13206-021-00004-5. Epub 2021 Feb 15.
Point-of-care (POC) molecular diagnostics for clinical microbiology and virology has primarily focused on the detection of a single pathogen. More recently, it has transitioned into a comprehensive syndromic approach that employs multiplex capabilities, including the simultaneous detection of two or more pathogens. Multiplex POC tests provide higher accuracy to for actionable decisionmaking in critical care, which leads to pathogen-specific treatment and standardized usages of antibiotics that help prevent unnecessary processes. In addition, these tests can be simple enough to operate at the primary care level and in remote settings where there is no laboratory infrastructure. This review focuses on state-of-the-art multiplexed molecular point-of-care tests (POCT) for infectious diseases and efforts to overcome their limitations, especially related to inadequate throughput for the identification of syndromic diseases. We also discuss promising and imperative clinical POC approaches, as well as the possible hurdles of their practical applications as front-line diagnostic tests.
用于临床微生物学和病毒学的即时检验(POC)分子诊断主要集中于单一病原体的检测。最近,它已转变为一种综合症状诊断方法,采用多重检测能力,包括同时检测两种或更多种病原体。多重POC检测为重症监护中的可操作决策提供了更高的准确性,从而实现针对病原体的治疗以及抗生素的标准化使用,有助于避免不必要的流程。此外,这些检测可以足够简单,以便在初级保健层面和没有实验室设施的偏远地区进行操作。本综述重点关注用于传染病的先进多重分子即时检验(POCT)以及克服其局限性的努力,特别是与症状性疾病识别时通量不足相关的局限性。我们还将讨论有前景且必要的临床POC方法,以及它们作为一线诊断检测实际应用时可能遇到的障碍。